If you’ve been researching treatment options for depression or trauma, you’ve probably seen TMS therapy mentioned. That usually leads to question it’s legitimacy.
The short answer is yes. Transcranial Magnetic Stimulation, or TMS, is an FDA-cleared treatment for certain mental health conditions. It is backed by clinical research and used in medical settings across the country.
What it is not is a cure-all. Like most treatments in behavioral health, it works best when integrated into a broader care plan, especially for individuals with addiction and co-occurring mental health disorders.
What Is TMS Therapy?
TMS stands for Transcranial Magnetic Stimulation. It is a non-invasive treatment that uses magnetic pulses to stimulate specific areas of the brain involved in mood regulation.
During a session:
- A magnetic coil is placed near the scalp
- Repeated magnetic pulses target areas linked to depression
- No anesthesia is required
- Patients remain awake
TMS does not involve medication and does not cause systemic side effects the way antidepressants sometimes can.
Is TMS FDA-Approved?
TMS is FDA-cleared for:
- Major depressive disorder
- Obsessive-compulsive disorder
- Smoking cessation (specific protocols)
It is most commonly used for individuals who have not responded adequately to antidepressant medications.
That regulatory clearance is one of the reasons TMS is considered a legitimate medical treatment, not an experimental therapy.
Does TMS Therapy Really Work?
Research shows that TMS can significantly reduce symptoms of depression in many individuals, particularly those with treatment-resistant depression.
Patients often report:
- Improved mood stability
- Increased energy
- Better focus
- Reduced hopelessness
Results are not instant. Treatment typically involves multiple sessions over several weeks.
TMS does not work for everyone, but its response rates are strong enough that it has become a standard option in psychiatric care.
TMS and Addiction Treatment
Addiction rarely exists in isolation. Many individuals struggling with substance use also experience:
- Depression
- Anxiety disorders
- PTSD
- Bipolar spectrum symptoms
When mental health symptoms remain untreated, relapse risk increases.
TMS may help by addressing underlying depressive symptoms that contribute to substance use. For some individuals, improved mood regulation can reduce the emotional triggers that drive relapse.
It is important to understand that TMS does not treat addiction directly. It does not eliminate cravings. It does not replace detox, therapy, or medication-assisted treatment.
Instead, it can support recovery by stabilizing the mental health component of dual diagnosis.
TMS and Dual Diagnosis
Dual diagnosis refers to the presence of both a substance use disorder and a co-occurring mental health condition.
In dual diagnosis treatment, both conditions must be addressed at the same time. Treating only the addiction without stabilizing depression or trauma often leads to cycling patterns.
TMS can be considered in cases where:
- Depression persists despite medication
- Side effects from psychiatric medication are problematic
- Mood instability contributes to relapse
- Traditional approaches have not provided sufficient improvement
When integrated into a comprehensive treatment plan, TMS may improve engagement in therapy and long-term recovery outcomes.
At Phoenix Rising Recovery, dual diagnosis care focuses on addressing both substance use and underlying mental health conditions simultaneously.
Is TMS Safe?
TMS is generally well tolerated. Common side effects include:
- Mild scalp discomfort
- Headache
- Temporary lightheadedness
Unlike electroconvulsive therapy (ECT), TMS does not cause memory loss and does not require sedation.
Serious side effects are rare but can include seizures in very uncommon cases, which is why proper screening is essential.
Who Is a Good Candidate for TMS?
TMS may be appropriate for individuals who:
- Have treatment-resistant depression
- Cannot tolerate antidepressant side effects
- Have persistent depressive symptoms affecting recovery
- Need a non-medication option
A psychiatric evaluation is required to determine candidacy.
So, Is TMS Therapy Legit?
Yes, TMS therapy is legitimate. It is FDA-cleared, research-backed, and widely used in psychiatric treatment.
But legitimacy does not mean universality. It is not for everyone, and it does not replace structured addiction treatment.
For individuals struggling with both substance use and depression, TMS may offer an additional layer of support when integrated into a comprehensive recovery plan.
Final Thoughts
Addiction and mental health conditions are deeply interconnected. When depression or trauma remains untreated, recovery becomes more difficult.
TMS therapy is one evidence-based option that may help stabilize mood and improve engagement in treatment. When combined with therapy, medical oversight, and structured recovery support, it can be part of a legitimate, well-rounded approach to dual diagnosis care.
Sources
- Conscious Health Center. (n.d.). TMS therapy in Los Angeles. https://conscioushealthcenter.com/tms-therapy-in-los-angeles/
- American Psychiatric Association. (n.d.). What is transcranial magnetic stimulation (TMS)? https://www.psychiatry.org/patients-families/what-is-tms
- National Institute of Mental Health. (n.d.). Brain stimulation therapies. https://www.nimh.nih.gov/health/topics/brain-stimulation-therapies/brain-stimulation-therapies
- U.S. Food and Drug Administration. (2018, August 17). FDA permits marketing of transcranial magnetic stimulation for treatment of obsessive-compulsive disorder. https://www.fda.gov/news-events/press-announcements/fda-permits-marketing-transcranial-magnetic-stimulation-treatment-obsessive-compulsive-disorder
- U.S. Food and Drug Administration. (2011, July 26). Repetitive transcranial magnetic stimulation (rTMS) systems: Class II special controls guidance. https://www.fda.gov/medical-devices/guidance-documents-medical-devices-and-radiation-emitting-products/repetitive-transcranial-magnetic-stimulation-rtms-systems-class-ii-special-controls-guidance
- U.S. Food and Drug Administration. (2008). K083538: Neuronetics NeuroStar TMS Therapy System 510(k) summary. https://www.accessdata.fda.gov/cdrh_docs/pdf8/k083538.pdf
- Mayo Clinic. (n.d.). Transcranial magnetic stimulation. https://www.mayoclinic.org/tests-procedures/transcranial-magnetic-stimulation/about/pac-20384625
- Ingham, J. (2026, February 24). What is TMS therapy and how does it relate to addiction treatment? Brooks Healing Center. https://brookshealingcenter.com/blog/tms-therapy/
- Cleveland Clinic. (n.d.). Transcranial magnetic stimulation (TMS): What it is. https://my.clevelandclinic.org/health/treatments/17827-transcranial-magnetic-stimulation-tms
- McClintock, S. M., Reti, I. M., Carpenter, L. L., McDonald, W. M., Dubin, M., Taylor, S. F., Cook, I. A., O’Reardon, J., Husain, M. M., Wall, C., Krystal, A. D., Sampson, S. M., Morales, O., Nelson, B. G., Latoussakis, V., George, M. S., & Lisanby, S. H. (2018). Consensus recommendations for the clinical application of repetitive transcranial magnetic stimulation (rTMS) in the treatment of depression. The Journal of Clinical Psychiatry, 79(1). https://pmc.ncbi.nlm.nih.gov/articles/PMC5846193/
- Mehta, D. D., Praecht, P., Gomes, T., Ho, C. H., & George, T. P. (2024). A systematic review and meta-analysis of neuromodulation therapies for substance use disorders. Neuropsychopharmacology. https://pubmed.ncbi.nlm.nih.gov/38086901/
- Centers for Medicare & Medicaid Services. (n.d.). Local coverage determination (LCD): Transcranial magnetic stimulation (TMS) (L33398). https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?lcdid=33398